Previous close | 25.81 |
Open | 26.11 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 25.89 - 26.21 |
52-week range | 23.53 - 37.50 |
Volume | |
Avg. volume | 78,040 |
Market cap | 147.501B |
Beta (5Y monthly) | 0.58 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.05 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.56 (5.99%) |
Ex-dividend date | 09 May 2024 |
1y target est | N/A |
Pfizer Inc. ( NYSE:PFE ) just released its first-quarter report and things are looking bullish. It was overall a...
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE).